Buscar
Mostrando ítems 1-4 de 4
Efetividade clínica do Análogo glargina no Diabetes Tipo 1: revisão sistemática e Coorte histórica
(Universidade Federal de Minas GeraisUFMG, 2016-04-29)
BACKGROUND: Diabetes mellitus (DM) has taken epidemic proportions in recent years, setting up a growing problem of global public health, mainly by causing damage to the patient in the clinical aspects, social, economic and ...
Efetividade clínica comparativa do análogo de Insulina Glargina com Insulina NPH para tratamento de pacientes com Diabetes Mellitus tipo 1
(Universidade Federal de Minas GeraisUFMG, 2015-08-03)
The insulin analogue glargine is dispensed, in the state of Minas Gerais, to patients with diabetes mellitus type 1 that attend to criteria of Health Secretariat of Minas Gerais (SESMG). Currently about 3200 patients are ...
Perfil de utilização do análogo glargina da insulina para o tratamento do Diabetes Mellitus Tipo I no Estado de Minas Gerais, Brasil
(Universidade Federal de Minas GeraisUFMG, 2012-12-19)
Introduction: Diabetes mellitus is a disease of great social and economic impact with relevant indicators in health. To control it requires a complex interaction of several factors, such as treatment adherence, diet, ...
Avaliação da qualidade de vida de pacientes acometidos por Diabetes Mellitus Tipo 1 tratados com análogo de insulina Glargina versus insulina NPH
(Universidade Federal de Minas GeraisUFMG, 2017-08-18)
INTRODUCTION: Diabetes Mellitus (DM) is a chronic disease that requires continuous medical care. In this sense, which is the way of life with a commitment to quality of life (QoL) over time. It is responsible for millions ...